about
Molecular genetic analysis of giant cell glioblastomasMolecular biology of gliomas: present and future challengesEctonucleotidases in tumor cells and tumor-associated immune cells: an overviewReactive retinal astrocytic tumors (so-called vasoproliferative tumors): histopathologic, immunohistochemical, and genetic studies of four cases.MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.Angiogenic growth factors in neural embryogenesis and neoplasiaGenetics of glioblastoma: a window into its imaging and histopathologic variability.A graphic method for identification of novel glioma related genes.Review: molecular pathology in adult high-grade gliomas: from molecular diagnostics to target therapiesMesenchymal migration as a therapeutic target in glioblastoma.Current review of in vivo GBM rodent models: emphasis on the CNS-1 tumour model.Pim1 kinase is upregulated in glioblastoma multiforme and mediates tumor cell survival.Gene therapy and targeted toxins for glioma.Inhibitors of Glioma Growth that Reveal the Tumour to the Immune System.Tumors associated with p53 germline mutations: a synopsis of 91 families.Up-regulation of specific NF 1 gene transcripts in sporadic pilocytic astrocytomas.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Emerging insights into the molecular and cellular basis of glioblastoma.MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.Prognostic indicators in a range of astrocytic tumours: an immunohistochemical study with Ki-67 and p53 antibodies.A role for glutamate in growth and invasion of primary brain tumorsFoxM1B transcriptionally regulates vascular endothelial growth factor expression and promotes the angiogenesis and growth of glioma cellsCells with intense EGFR staining and a high nuclear to cytoplasmic ratio are specific for infiltrative glioma: a useful marker in neuropathological practiceGenetically engineered mouse models of brain cancer and the promise of preclinical testingNovel Perspectives on p53 Function in Neural Stem Cells and Brain TumorsMutations in the p53 Tumor Suppressor Gene: Important Milestones at the Various Steps of TumorigenesisSilencing of the hTERT gene through RNA interference induces apoptosis via bax/bcl-2 in human glioma cellsThe receptor interacting protein 1 inhibits p53 induction through NF-kappaB activation and confers a worse prognosis in glioblastoma.The nuclear receptor tailless induces long-term neural stem cell expansion and brain tumor initiation.Mutant IDH1-specific immunohistochemistry distinguishes diffuse astrocytoma from astrocytosisMultiple polymorphisms, but no mutations, in the WAF1/CIP1 gene in human brain tumours.A sensitive and specific diagnostic panel to distinguish diffuse astrocytoma from astrocytosis: chromosome 7 gain with mutant isocitrate dehydrogenase 1 and p53Gene therapy and targeted toxins for glioma
P2860
Q24678750-AF87DC13-4CC6-4D40-A93C-810EC5BC2B78Q27001295-75884DCA-816C-4E39-88D0-ACE90E8BA976Q27002950-2ACADDF7-8D10-492A-B5EB-75E956CBFEF9Q30409080-A6854704-1492-4949-9BEC-CC6115A065F0Q30434616-9FA24667-4181-4743-B389-64B8B076619AQ30498863-7BD03257-6904-46FA-8CCB-33A4876CF486Q33620506-49BE6801-BCBF-4FA2-8FCE-1CC4F8A20F89Q33891429-C745D1D9-A8B2-401F-9A23-AD5A35C77538Q33925544-695AC315-5D47-4B75-9608-718515A1795DQ34002994-024FFFC2-1FB8-40B7-BBA8-F0C773D27679Q34198939-567F8767-7E66-4B12-8D48-EE361178CA0FQ34886884-113D4F7D-AED2-41AB-9D41-FED80409BFF5Q35118933-DF4F7319-8ADE-4A51-9F38-2DFFD5DB340FQ35440540-2253DD5F-9E80-4E39-81D0-AEA6D374A482Q35765327-B82DAAEA-A1F7-4DAC-95CB-0EEA6842E635Q35782539-AD79799A-DA5D-4697-985A-EF7D9C668203Q35799695-FF0C8FDC-6A98-4993-BD06-0399660918ABQ35914897-A3D4FB4A-7FE5-428E-B155-CF1EA5DC150FQ36431757-7CEE3ED8-3310-4486-9381-80269AA801C1Q36882527-CAEDEE3C-9546-42AF-8206-3DF7ECE83EA1Q36917114-4E279053-E1AA-47D2-817B-C4357340C10DQ37003673-C59D620C-F329-42E1-9FD6-548E3677947BQ37187711-18AB3C28-EEF1-4867-A61F-9718B9444457Q37348716-067C1142-1834-44C0-825F-642C178E877DQ37826349-8054FBAD-5B31-420C-B397-C61663F9C2A4Q37903701-10EFD77F-8DB5-47B1-8942-F1096453F00FQ39296941-BE67C14E-B08A-449F-AC46-6D12B2D277E0Q39865435-659133AD-2670-43C2-BA41-29CEC93503C4Q39889217-E65F720B-8269-4193-9060-73DB3FD508BBQ40370855-99D6862B-BF32-4321-A8E2-6B926ECDCC57Q42590778-EE7CCE22-FA7E-469A-BDB2-11D737D3E3CEQ42701448-E150139E-66A4-4C2B-BB02-6AB89C2222C3Q57006162-7E0C44A5-0AF6-4399-8B99-B5DE0804DDA5
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
The p53 gene and protein in human brain tumors.
@en
type
label
The p53 gene and protein in human brain tumors.
@en
prefLabel
The p53 gene and protein in human brain tumors.
@en
P1476
The p53 gene and protein in human brain tumors.
@en
P2093
P577
1994-01-01T00:00:00Z